BPC-157 vs TB-500 for recovery
Short answer: For recovery, users rate them about the same: 96% report improvement with BPC-157 (494 reports) and 96% with TB-500 (297 reports).
BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; TB-500 has 0 and 3.
Based on 1,613 reports about BPC-157 and 874 about TB-500. Not medical advice.
| BPC-157 Peptide | TB-500 Peptide | |
|---|---|---|
| Users say it helped | 54%helped919 reports · high confidence | 65%helped402 reports · high confidence |
| Verdict | Mixed | Mostly positive |
| Research | DResearch: None | CResearch: Limited |
| Meta-analyses / RCTs | 0 / 0 | 0 / 3 |
| Mainly used for | ||
| Recovery % reporting improvement | 96% (494) | 96% (297) |
| Pain & inflammation % reporting improvement | 86% (485) | 86% (199) |
| Mood % reporting improvement | 65% (128) | 91% (11) |
| Digestion % reporting improvement | 84% (111) | 100% (2) |
| Performance % reporting improvement | 95% (61) | 96% (26) |
| Common side effects | fatigue, anhedonia, anxiety, headache | anxiety, fatigue, dizziness, allergic reaction |
| Typical dose reported | Not listed | Not listed |
BPC-157Full BPC-157 profile →
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
TB-500Full TB-500 profile →
What a user said
“They reduce neuroinflammation in the brain caused by either head injuries or drug abuse. Ive used them both for this and it works.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate